Set a reminder here 👉
x.com/i/spaces/1M...

$BeeARD's onchain scientist is cooking 👨‍🍳

Don't forget to tune in to our Space with the @BeeARDAi team today, August 11 at 5:30 PM CET.

Check out $URO and other trending tokens on @solana on our screener
molecule.xyz/?utm_source...

With Molecule labs it's easier than ever to track all data from all @pumpdotscience experiments.

All through one Platform.

Did you know that all experiment data from $URO will be streamed into $URO's own Molecule labs page?

Watching flies > watching charts

Since launching on Molecule, $URO has been trending on our screener 🔥

Check out $RIF and other trending tokens on @solana on our screener 👉
molecule.xyz/?utm_source...

Did you know that all experiment data from $RIF is going to be streamed into $RIF's own Molecule labs page?

> Easier than ever to track all data from all @pumpdotscience experiments.

$RIF has been trending on our screener this week and is the #1 IP Token traded by volume 🔥

Stake. Yap. Accelerate.
👇
twitter.com/Molecule_da...">August

If only there was a way to get access to @BioProtocol launches before they get listed on the big dog CEXs...

Oh wait...😏 Have you checked BioXP yet??

More XP = more access to Bio's upcoming launches 👀
twitter.com/BioProtocol...">August

$BEEARD’s AI researcher is breaking new ground, and we’ve got questions.

Join us Monday, August 11 at 17:30 CET for an X Space with the @BeeARDAi team, who is behind one of the most ambitious experiments at the edge of DeSci, AI, and psychedelics.

Set a reminder 🔔
x.com/i/spaces/1M...

$BEEARD’s AI researcher is breaking new ground, and we’ve got questions.

Join us Monday, August 11 at 17:30 CET for an X Space with the team behind one of the most ambitious experiments at the edge of DeSci, AI, and psychedelics.

Set a reminder 🔔
x.com/i/spaces/1M...

HEMPY $0.000412 | $412K market cap | +0.95% HEMPY price $0.000412, market cap $412K, volume $94.65. Biotechnology IP token with governance rights. Live data on Molecule.xyz.

Sustainable, soft and water resistant hemp clothing is becoming a reality.
You can track the underlying IP here 👉
molecule.xyz/ipts/hempy?...

$HEMPY could now be used in outdoor wear, extreme sports gear, and technical apparel where water resistance is key.

By attaching specific molecules to the hemp fibers, the team was able to increase their hydrophobicity.

These upgraded fibers can now repel water and resist absorption, all while staying soft on the body.

$HEMPY just unlocked a brand new property of hemp

From "soaks everything" to "performance textile", water repellent hemp is becoming reality.

New drop from the frontlines of climate science
🧵👇

Check out $OMIPAL and other trending tokens on @solana on our screener 👉
molecule.xyz/?utm_source...

With Molecule labs it's easier than ever to track all experiment data from @pumpdotscience tokens.

Brainrot for PhDegens.

Did you know that all experiment data from $OMIPAL will be streamed automatically into $OMIPAL's own Molecule labs?

$OMIPAL is one of the top gainers on our screener this week -- and live experiment data is on its way 👀

Abu Dhabi is backing longevity innovation!

Alana and @EMcCarthyPage explain how Abu Dhabi is helping researchers fast-track biotech.

Watch the full episode here:
youtu.be/569wgffQzis

Since launch, @pumpdotscience has seen over 50,000 unique wallets hold IPTs, with millions in daily trading volume.

Sol maxi, or just curious? Check out the full range of IPTs available for trading on Solana here 👉
molecule.xyz/?utm_source...

Last week, all @pumpdotscience tokens went live on Molecule.
Tomorrow, new experiments are already launching: Aug 7--You might want to pay attention 👀
twitter.com/pumpdotscie...">August

More users hold IP Tokens on @solana than any other chain.

Science season is just getting started. ✨

Track the underlying IP of $VITA-FAST and other research here 👉
molecule.xyz/?utm_source...

Two projects. Two serious trial discussions.
One platform where science moves faster because you can move it: Molecule.

The $VITA-FAST team is currently:
> Securing IP
> Engaging UAE regulators
> Assessing trial feasibility

If approved, the UAE trial could lead to a Phase 2 clinical trial, targeting real-world autophagy enhancement with a validated compound.

Autophagy is one of the most promising pathways in aging and metabolic health, but many candidates don't deliver meaningful effect sizes at tolerable does.

VFDP-14 has demonstrated promise and is already on the market.

$VITA-FAST just submitted a research proposal for a new compound: VFDP-14.

VFDP-14 is a commercially available compound showing exceptional autophagy activity.
Now, $VITA-FAST is scoping a potential trial in the UAE.